Faron Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Faron Pharmaceuticals Oy(“Faron” or “Company”) Faron Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference Press release TURKU, FINLAND / BOSTON, MA – January 3, 2024 - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate immunity in hematological and solid tumor microenvironments, today announces that Dr. Markku Jalkanen, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday